Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Von Willebrand Disease: later-stage trial registry
1 of 4 indexed Von Willebrand Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Von Willebrand Disease: 4 US clinical trials tracked, 1 recruiting.
Von Willebrand Disease is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Baxalta now part of Shire, running 2 of these trials.
Enrollment posture brief
Registry condition von-willebrand-disease
OPEN 1 | RECR 25% | LATE 3 | EARLY 0 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Von Willebrand Disease lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Von Willebrand Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Von Willebrand Disease is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
Baxalta now part of Shire
NCT02932618
rVWF IN PROPHYLAXIS
Takeda
NCT02973087
Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery
Baxalta now part of Shire
NCT02283268
The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
Mary M. Gooley Hemophilia Center
NCT00697385
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Von Willebrand Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Von Willebrand Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Von Willebrand Disease page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Von Willebrand Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Baxalta now part of Shire sponsors the most Von Willebrand Disease trials on record, review their full trial history before evaluating a specific study. See Baxalta now part of Shire's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Von Willebrand Disease condition card totals 4 registered trials; most-linked intervention Antihemophilic Factor (Recombinant); top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.